ACR Price sensitive 6 Aug 2026, 9:02 AM

Investor Presentation - Female Testosterone for HSDD

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.